For research use only. Not for therapeutic Use.
Magrolimab (Hu5F9-G4) is a first-in-class humanized anti-CD47 IgG4 antibody with an anti-tumor activity[1].
| Catalog Number | I043770 |
| CAS Number | 2169232-81-7 |
| Purity | ≥95% |
| Reference | [1]. Caner Saygin, et al. Current and emerging strategies for management of myelodysplastic syndromes. Blood Rev. 2021 Jul;48:100791. |
